BiotechTube
Home/PRM Pharma/Joseph T. McDevitt
JT

Joseph T. McDevitt

President and CEO

PRM Pharma

Therapeutic Areas

CardiovascularRare DiseaseMetabolic

PRM Pharma Pipeline

DrugIndicationPhase
HemiClor (hydrochlorothiazide 6.25 mg)Hypertension in adultsApproved

Leadership Team at PRM Pharma

MS
Melvin Sharoky, MD
Head, Corporate and Scientific Affairs
PR
Peter R. Kowey, MD
Head, Cardiovascular Products
DM
Deborah Maroko, MD
Head, Medical Affairs
View full PRM Pharma profile